Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV trial comparing immunogenicity of hepatitis B vaccines in immunosuppressed patients
2018-002368-18Phase 4Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Jul 2018
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Hepatitis B vaccine and Recombivax HB in hepatitis B (HBV) (2 arms), sponsored by Vall d'Hebron Research Institute. Primary endpoint: Primary immunogenicity endpoint. Started Jul 2018; status: completed.
02
Drugs
Hepatitis B vaccineRecombivax HB
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2018-002368-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002368-18.